Clinical Trial: Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever

U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07314281) titled 'Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever' on Sept. 17, 2025.

Brief Summary: 1. Primary Objective:

o To evaluate the efficacy of intravenous azithromycin compared with meropenem in the treatment of extensively drug-resistant (XDR) enteric fever.

2. Secondary Objectives:

* To evaluate the fever defervescence and Salmonella Typhi eradication

* To evaluate the cost-effectiveness of intravenous azithromycin versus meropenem in treating XDR enteric fever.

3. Exploratory Objectives:

* To evaluate the drug resistance against intravenous azithromycin versus in treating XDR enteric fever.

Study Start Date: April 22, ...